Source NJBiz.com Health
A new multipractice ambulatory surgery center is now open in Newark.
Developer and manager of ambulatory surgery centers Frontier Healthcare partnered to open Mulberry Ambulatory Surgical Center facility in the Ironbound section of Newark, to offer gastroenterology, pain management and orthopedic procedures.
The 10,700-square-foot, state-of-the-art facility is Frontier’s first in New Jersey. The company has opened and managed 11 ambulatory surgery centers in New York.
“We’re very proud of our role in helping the physician-owners of Mulberry ASC overcome a number of challenges to open their facility,” said Roy Bejarano, president of Frontier Healthcare, said in a statement. “With Frontier’s resources and expertise, the Mulberry Center was able to assist the founder in recruiting new physicians and provide back office support to gain joint commission accreditation.”
Frontier said it aggressively marketed to get physicians on board and expects several to join the center within the next month. They will help to manage the facility in partnership with the physicians.
Hengrui Therapeutics Inc. held a ribbon-cutting in West Windsor Township as it announced its opening as the clinical oncology research affiliation of one of China’s largest pharmaceutical companies, Jiangsu Hengrui Medicine. “Our journey officially starts here,” said Adam Zong, CEO and president of HTI. According to a statment, HTI is tasked with the development and commercialization of innovative cancer therapies.
“Mankind’s collective fight against cancer will have more ingenuity, wisdom and our share of blood and sweat, and, eventually, our contributions,” Zong added. “Our endeavors are very exciting. At the same time, we are very aware of the challenges and setbacks that lie ahead. Our pledge is to dig in our heels and persevere until we are triumphant.”
New Jersey Department of Health commissioner Cathleen Bennett said the opening of the company was exciting since it would encourage people to stay in New Jersey, especially with such a strong biopharmaceutical work force already in the state: “The industry has grown from about 30 biotechs in 1994 to over 400 today, and they have come from every possible angle. We have representation from around the world.”
In a statement, Zong said: “We a can effectively support a robust, clinical-staged pipeline and deliver innovative medicines to patients in need. It will lay a good foundation for our company’s long-term growth.”